EUVIMEDEUVIMED entdecken
Crossref

Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles

Zhao Wang, Wenbo Wang, Zhen Gao, Huizhan Gao, Erik De Clercq, Christophe Pannecouque, Chin-Ho Chen, Dongwei Kang iD, Peng Zhan, Xinyong Liu

Journal of Medical Virology · 2024

DOI: 10.1002/jmv.29830 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Medical Virology, 2024. Verfasst von Zhao Wang und 9 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of …. Hauptthemen laut MEDLINE: HIV-1, Molecular Docking Simulation, Anti-HIV Agents, Drug Design. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 38 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Science Foundation for Outstanding Young Scholars of Shandong Province, Science Foundation for Excellent Young Scholars of Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

In the current antiretroviral landscape, continuous efforts are still needed to search for novel chemotypes of human immunodeficiency virus type 1 (HIV‐1) inhibitors with improved drug resistance profiles and favorable drug‐like properties. Herein, we report the design, synthesis, biological characterization, and druggability evaluation of a class of non‐nucleoside reverse transcriptase inhibitors. Guided by the available crystallographic information, a series of novel indolylarylsulfone derivatives were rationally discovered via the substituent decorating strategy to fully explore the chemical space of the entrance channel. Among them, compound 11h bearing the cyano‐substituted benzyl moiety proved to be the most effective inhibitor against HIV‐1 wild‐type and mutant strains (EC 50 = 0.0039–0.338 μM), being far more potent than or comparable to etravirine and doravirine. Besides, 11h did not exhibit cytotoxicity at the maximum test concentration. Meanwhile, the binding target of 11h was further confirmed to be reverse transcriptase (IC 50 = 0.055 μM). Preliminary structure–activity relationship were discussed to guide further optimization work. Molecular docking and dynamics simulation studies were investigated in detail to rationalize the biological evaluation results. Further drug‐likeness assessment indicated that 11h possessed excellent physicochemical properties. Moreover, no apparent hERG blockade liability and cytochrome P450 inhibition were observed for 11h . Notably, 11h was characterized by favorable in vitro metabolic stability with moderate clearance rates and long half‐lives in human plasma and liver microsomes. Overall, 11h holds great promise as an ideal Anti‐HIV‐1 lead compound due to its potent antiviral efficacy, low toxicity, and favorable drug‐like profiles.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HIV-1Molecular Docking SimulationAnti-HIV AgentsDrug DesignSulfonesReverse Transcriptase InhibitorsHumansStructure-Activity RelationshipHIV Reverse Transcriptase

Stichwörter der Autor:innen

HIV‐1biological evaluationindolylarylsulfone derivativesmolecular dynamics simulationstructure‐based design

Substanzen

Anti-HIV AgentsSulfonesReverse Transcriptase InhibitorsHIV Reverse Transcriptasereverse transcriptase, Human immunodeficiency virus 1

Autor:innen und Institutionen

  • Key Laboratory of Chemical Biology (Ministry of Education), Department of Medicinal Chemistry, School of Pharmaceutical Sciences, Cheeloo College of Medicine, Shandong University, Jinan, Shandong, China.
  • China-Belgium Collaborative Research Center for Innovative Antiviral Drugs of Shandong Province, Jinan, Shandong, China.
  • Suzhou Research Institute of Shandong University, Suzhou, Jiangsu, China.
  • Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, K.U. Leuven, Leuven, Belgium.
  • Surgical Oncology Research Facility, Duke University Medical Center, Durham, North Carolina, USA.

ORCID-Profile: Dongwei Kang

Förderung

  • National Natural Science Foundation of China
  • Science Foundation for Outstanding Young Scholars of Shandong Province
  • Science Foundation for Excellent Young Scholars of Shandong Province
  • Foreign Cultural and Educational Experts Project
  • China Postdoctoral Science Foundation
  • Shandong Province Natural Science Foundation for Youths
  • Natural Science Foundation of Jiangsu Province
  • Qilu Young Scholars Program of Shandong University

Zitieren

APA

Wang, Z., Wang, W., Gao, Z., Gao, H., Clercq, E., Pannecouque, C., Chen, C. H., Kang, D., Zhan, P., & Liu, X. (2024). Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles. Journal of Medical Virology. https://doi.org/10.1002/jmv.29830

Vancouver

Wang Z, Wang W, Gao Z, Gao H, Clercq E, Pannecouque C, et al. Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles. Journal of Medical Virology. 2024. doi:10.1002/jmv.29830

BibTeX
@article{Wang2024,
  author = {Wang, Zhao and Wang, Wenbo and Gao, Zhen and Gao, Huizhan and Clercq, Erik De and Pannecouque, Christophe and Chen, Chin-Ho and Kang, Dongwei and Zhan, Peng and Liu, Xinyong},
  title = {Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral activities and favorable drug‐like profiles},
  journal = {Journal of Medical Virology},
  year = {2024},
  doi = {10.1002/jmv.29830}
}
Kostenlos starten →